From Early Value Signals to Access: HEOR, Procurement and Contracting

February 17, 2027

Back to all webinars

Title: From Early Value Signals to Access: HEOR, Procurement and Contracting

Wednesday, February 17, 2027
11:00AM EST | 4:00PM UTC | 5:00PM CET

Click here for time zone conversion

Registration Coming Soon!

Description

Health economics and outcomes research (HEOR) is increasingly expected to inform healthcare decisions before key development, evidence, investment, and access pathways become fixed. Yet a gap remains between early economic evidence and its use in real-world decision-making. In MedTech, diagnostics, and digital health, where evidence is often evolving and uncertainty remains high, early modeling and value definition can generate decision-relevant value signals. However, these signals do not consistently influence upstream go/no-go decisions, evidence generation, or downstream access, procurement, and value-based contracting. 
 
This webinar will examine how early HEOR can be translated into healthcare decisions across the innovation lifecycle. The moderator will frame the evidence-to-access chain and where it can break. The first speaker will examine early modeling as decision support under uncertainty and its role in generating value signals before pathways become fixed. The second will provide a system-level and policy perspective on value, including the need for earlier alignment on value dimensions and decision-relevant outcomes. The third will discuss how value is operationalized in procurement and value-based contracting and how early HEOR insights could better inform these processes. 
 
Following brief presentations, an interactive discussion will explore where the link between early HEOR and access breaks, whether earlier stakeholder engagement can strengthen the chain, and what structural or methodological changes are needed.


Learning Objectives

  • Explain how early HEOR and value signals can support development, evidence generation, and access decisions before pathways become fixed. 
  • Identify where the evidence-to-access chain breaks between early value definition, stakeholder alignment, procurement, and value-based contracting. 
  • Assess practical ways to strengthen alignment between early HEOR, system-level value definition, and downstream procurement and contracting decisions. 

Moderator:

Björn Schwander, PhD, Founder and General Manager, AHEAD GmbH; Member Engagement Cochair, ISPOR Medical Devices & Diagnostics SIG, Bietigheim-Bissingen, Germany

Speakers:

Julie Frappier, BS, MSc, Founder and CEO, Data 4 Actions Inc. & TOWWERS 4 Actions Inc., Montreal, Canada

Sally Lewis, MBBS, Professor of Value in Health Management, Swansea University; Founder, Kintsugi International, Newport, Wales, United Kingdom 

Hans Bax, MBA, Executive Procurement Consultant, BPC; Senior Advisor Market Access, MedTech Europe; Lecturer Public Procurement, NEVI, Coevorden, the Netherlands 

Brought to you by the ISPOR Medical Devices and Diagnostics Special Interest Group.

Please note: On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 days after the scheduled Webinar. Reservations are on a first-come, first-served basis.

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×